|
GXYLT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.227200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.011600E-01 |
| Normal-vs-Stage2 |
7.773600E-01 |
| Normal-vs-Stage3 |
1.642790E-01 |
| Normal-vs-Stage4 |
1.368800E-01 |
| Stage1-vs-Stage2 |
4.846200E-01 |
| Stage1-vs-Stage3 |
9.028000E-02 |
| Stage1-vs-Stage4 |
1.009820E-01 |
| Stage2-vs-Stage3 |
3.665800E-01 |
| Stage2-vs-Stage4 |
1.238980E-01 |
| Stage3-vs-Stage4 |
4.729200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.472800E-01 |
| Normal-vs-AfricanAmerican |
5.759800E-01 |
| Normal-vs-Asian |
2.885000E-01 |
| Caucasian-vs-AfricanAmerican |
9.141600E-01 |
| Caucasian-vs-Asian |
1.128170E-01 |
| AfricanAmerican-vs-Asian |
3.390600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.071400E-01 |
| Normal-vs-Female |
4.582300E-03 |
| Male-vs-Female |
1.556770E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.229400E-01 |
| Normal-vs-Extreme_Weight |
9.559500E-02 |
| Normal-vs-Obese |
1.186190E-01 |
| Normal-vs-Extreme_Obese |
1.693210E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.347630E-01 |
| Normal_Weight-vs-Obese |
3.764800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.685400E-01 |
| Extreme_Weight-vs-Obese |
9.741300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.012800E-01 |
| Obese-vs-Extreme_Obese |
1.191850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.840500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.309600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.683800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.467600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.779950E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.673800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.340300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.735000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.002160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.441000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.604000E-01 |
| Normal-VS-Type2 PRCC |
4.734400E-01 |
| Normal-VS-KIRP CIMP |
2.402200E-02 |
| Normal-VS-Unclassified PRCC |
1.652410E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.381400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.625500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.075000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.929790E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.367600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.119700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.842400E-02 |
| Normal-vs-N1 |
4.961700E-03 |
| Normal-vs-N2 |
2.545800E-01 |
| N0-vs-N1 |
9.420800E-04 |
| N0-vs-N2 |
1.926760E-01 |
| N1-vs-N2 |
8.246600E-01 |
|
|
